Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. (Q36619873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author

Eleftherios P. Diamandis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Yu H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Levesque MA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Clark GM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

490-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer

31 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

The regulation of p53 function: Steiner Award Lecture.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Cell cycle control and cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Molecular foundations of cancer: New targets for intervention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Induction of the growth inhibitor IGF-binding protein 3 by p53

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Progesterone receptors and human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Evaluation of survival data and two new rank order statistics arising in its consideration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Tumourigenesis associated with the p53 tumour suppressor gene

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

False positive prostate specific antigen values in the sera of women with renal cell carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362935

Prostate specific antigen — a new constituent of breast cyst fluid

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Immunohistochemical identification ofprostatic acid phosphatase and prostate specific antigen in female periurethral glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Multifactorial analysis of p53 alteration in human cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Detection of prostate-specific antigen immunoreactivity in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690720

Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium

21 January 2018

1 reference

12 December 2020

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

12 December 2020

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Prostate-specific antigen in milk of lactating women

1 reference

12 December 2020

Prostate-specific antigen immunoreactivity in amniotic fluid

1 reference

12 December 2020

Assessment of p53 overexpression by non-immunohistochemical methods

1 reference

12 December 2020

Expression of the prostate-specific antigen gene by a primary ovarian carcinoma

1 reference

12 December 2020

Time-resolved immunofluorometric assay of p53 protein

1 reference

12 December 2020

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis

1 reference

12 December 2020

Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers

1 reference

12 December 2020

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

12 December 2020

Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10507775%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

10507775

1 reference